Association of doxycycline use with the development of gastroenteritis, irritable bowel syndrome and inflammatory bowel disease in <scp>A</scp>ustralians deployed abroad

Abstract

The use of doxycycline is a risk factor for developing IBS and possibly IBD when deployed to developing and developed countries respectively. Doxycycline as a risk factor for chronic gastrointestinal illness warrants a prospective large-scale study.